1. Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. Issue 1 (January 2022) Authors: Mauz-Körholz, Christine; Landman-Parker, Judith; Balwierz, Walentyna; Ammann, Roland A; Anderson, Richard A; Attarbaschi, Andische; Bartelt, Jörg M; Beishuizen, Auke; Boudjemaa, Sabah; Cepelova, Michaela; Claviez, Alexander; Daw, Stephen; Dieckmann, Karin; Fernández-Teijeiro, Ana; Fosså, Alexande... Journal: Lancet oncology Issue: Volume 23:Issue 1(2022) Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study. Issue 3 (March 2023) Authors: Mauz-Körholz, Christine; Landman-Parker, Judith; Fernández-Teijeiro, Ana; Attarbaschi, Andishe; Balwierz, Walentyna; Bartelt, Jörg M; Beishuizen, Auke; Boudjemaa, Sabah; Cepelova, Michaela; Ceppi, Francesco; Claviez, Alexander; Daw, Stephen; Dieckmann, Karin; Fosså, Alexander; Gattenlöhner, Stefa... Journal: Lancet oncology Issue: Volume 24:Issue 3(2023) Page Start: 252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗